A Pharmaceutical giant, Wellcome and the Bill & Melinda Gates Foundation have announced funding, to advance a tuberculosis (TB) vaccine candidate, M72/AS01E (M72), through a Phase III clinical trial.
Trending
- G20 leaders inaugurate global alliance to end hunger
- CISLAC applauds Supreme Court for upholding EFCC’s authority
- YouthWASH urges prioritisation of toilets, sanitation
- Lassa fever: Physician emphasises improved household, community hygiene
- Foreign coys to partner NADF on cassava industrialisation in Nigeria
- Constant sexual intercourse doesn’t prevent prostate cancer– urologist
- Experts demand urgent action on adolescent health
- Floods hit Northern Philippines after Typhoon forces dam release
